The acceleration in job growth came after the November elections, when therapidrise in government spending ended and the risk of higher tax rates on those with high incomes was removed.
There is exceptional focus right now on young children's development, in part because of therapidrise in autism diagnoses, now at 1 in 88 U.S. children, according to the Centers for Disease Control and Prevention.